- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
阵发性房颤射频消融术后应用胺碘酮对复发率影响的研究.doc
阵发性房颤射频消融术后应用胺碘酮对复发率影响的研究
【摘要】 目的 探讨阵发性心房颤动(房颤)射频消融术后应用胺碘酮对复发率的影响。方法 48例阵发性房颤行射频消融术患者, 均术前常规停用抗心律失常药物, 术中采用环肺静脉隔离方法, 术后随机分为胺碘酮组与非抗心律失常药物组, 各24例。胺碘酮组口服胺碘酮3个月, 其他治疗同非抗心律失常药物组。观察两组的复发情况。结果 胺碘酮组复发率:首次治疗1周时为20.8%(5/24), 1个月时为12.5%(3/24), 3个月时为12.5%(3/24), 12个月时为8.3%(2/24)。非抗心律失常药物组复发率:首次治疗1周时为50.0%(12/24), 1个月时为37.5%(9/24), 3个月时为37.5%(9/24), 12个月时为8.3%(2/24)。两组首次治疗1周及治疗1、3个月时复发率比较差异具有统计学意义(P0.05)。结论 阵发性房颤射频消融术后应用胺碘酮治疗可影响对3个月内复发率的判断, 对12个月时的复发率无影响。
【关键词】 阵发性心房颤动;射频消融术;胺碘酮;复发
DOI:10.14163/j.cnki.11-5547/r.2016.19.005
Research of influence by amiodarone applied after paroxysmal atrial fibrillation radiofrequency ablation on recurrence rate ZHANG Fang, XIA Zhen-wei, FENG Lei, et al. Liaoning Province Dalian City Central Hospital, Dalian 116033, China
【Abstract】 Objective To investigate influence by amiodarone applied after paroxysmal atrial fibrillation radiofrequency ablation on recurrence rate. Methods A total of 48 paroxysmal atrial fibrillation radiofrequency ablation patients received preoperative withdrawal of conventional antiarrhythmic drug and intraoperative circumferential pulmonary vein isolation. After operation, they were randomly divided into amiodarone group and non-antiarrhythmic drug group, with 24 cases in each group. The amiodarone group received oral administration of amiodarone for 3 months, and its following treatment is the same as the non-antiarrhythmic drug group. Recurrence condition was observed in both groups. Results The amiodarone group had recurrence rates as 20.8% (5/24) in 1 week of treatment, 12.5% (3/24) in 1 month, 12.5% (3/24) in 3 months and 8.3% (2/24) in 12 months. The non-antiarrhythmic drug group had recurrence rates as 50.0% (12/24) in 1 week of treatment, 37.5% (9/24) in 1 month, 37.5% (9/24) in 3 months and 8.3% (2/24) in 12 months. The difference of recurrence rates in 1 week, 1 and 3 months of treatment had statistical significance between the two groups (P0.05). Conclusion Application of amiodarone after paro
文档评论(0)